or Try an Advanced Search...

    Technical Analysis for INVO - INVO BioScience, Inc.

    Grade Last Price % Change Price Change
    F 0.93 8.14% 0.07
    INVO closed up 8.14 percent on Tuesday, May 7, 2024, on 5 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    Earnings due: May 13
    *** please verify all earnings dates ***
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical INVO trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Narrow Range Bar Range Contraction 8.14%
    Wide Bands Range Expansion 8.14%
    Down 3 Days in a Row Weakness 8.14%
    Oversold Stochastic Weakness 8.14%
    Spinning Top Other 0.55%
    NR7 Range Contraction 0.55%
    Narrow Range Bar Range Contraction 0.55%
    Wide Bands Range Expansion 0.55%
    Older End-of-Day Signals for INVO ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout about 13 hours ago
    Up 3% about 13 hours ago
    Possible NR7 about 13 hours ago
    Possible Inside Day about 13 hours ago
    Up 2% about 17 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    INVO Chart by TradingView
    Basic chart:

    Profile

    INVO BioScience, Inc. Description

    INVO Bioscience, Inc. is an innovative medical device company developing solutions for the global infertility industry. INVO's goal is to increase access to care and expand fertility treatment across the globe while seeking to lower the cost and increase the availability of care. INVO's lead commercial product, the INVOcell, is a patented Assisted Reproductive Technology (ART) used in the treatment of infertility. The INVOcell device and procedure is unique as the first Intravaginal Culture (IVC) system in the world used for the natural in vivo incubation of eggs and sperm during fertilization and early embryo development. As an alternative to traditional in Vitro Fertilization (IVF), the revolutionary in vivo method of vaginal incubation offers patients a more natural and intimate experience. INVO Bioscience is headquartered in Sarasota, FL.

    Classification
    Sector: Healthcare
    Industry: Medical Devices
    Keywords: In Vitro Fertility Eggs Infertility Reproduction Fertility Medicine Vagina Assisted Reproductive Technology Human Reproduction In Vitro Fertilisation In Vitro Fertilization Embryo Transfer

    Is INVO a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 3 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 16 INVO BioScience reports Q4 results
    Apr 16 INVO Reports Fourth Quarter and Full Year 2023 Financial Results
    Jan 23 NAYA Biosciences to buy gene therapy company Florida Biotechnologies
    Jan 23 NAYA Biosciences To Acquire Clinical Stage Gene Therapy Program for Leber's Hereditary Optic Neuropathy (LHON)
    Jan 17 INVO, NAYA announce new board members ahead of merger
    Jan 17 INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board Directors
    Dec 11 NAYA Biosciences Announces Publication of New Data for its CD38-targeted Flex-NK™ Bispecific Antibody in the American Society of Hematology's Blood Journal
    Dec 6 NAYA, ONK team up to evaluate potential cancer therapy combinations
    Dec 6 NAYA Biosciences and ONK Therapeutics Announce Research Partnership to Advance Combination Therapy of FLEX-NK™ Bispecific Antibodies and Optimally Engineered Off-the-Shelf Natural Killer Cell Therapies
    Nov 28 INVO Bioscience regains compliance with Nasdaq rule
    See more INVO news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 8.6
    52 Week Low 0.5
    Average Volume 4,828,349
    200-Day Moving Average 1.31
    50-Day Moving Average 1.06
    20-Day Moving Average 1.06
    10-Day Moving Average 0.98
    Average True Range 0.20
    RSI (14) 45.95
    ADX 32.36
    +DI 39.38
    -DI 23.36
    Chandelier Exit (Long, 3 ATRs) 2.90
    Chandelier Exit (Short, 3 ATRs) 1.30
    Upper Bollinger Bands 1.59
    Lower Bollinger Band 0.52
    Percent B (%b) 0.38
    BandWidth 100.79
    MACD Line -0.03
    MACD Signal Line 0.00
    MACD Histogram -0.0293
    Fundamentals Value
    Market Cap 2.32 Million
    Num Shares 2.49 Million
    EPS -10.34
    Price-to-Earnings (P/E) Ratio -0.09
    Price-to-Sales 1.22
    Price-to-Book 6.16
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.08
    Resistance 3 (R3) 1.07 1.02 1.06
    Resistance 2 (R2) 1.02 0.98 1.02 1.05
    Resistance 1 (R1) 0.97 0.96 1.00 0.98 1.04
    Pivot Point 0.92 0.92 0.93 0.92 0.92
    Support 1 (S1) 0.87 0.88 0.90 0.88 0.82
    Support 2 (S2) 0.82 0.85 0.82 0.81
    Support 3 (S3) 0.77 0.82 0.80
    Support 4 (S4) 0.78